| Literature DB >> 20962846 |
Kamran Ghoreschi1, Arian Laurence, Xiang-Ping Yang, Cristina M Tato, Mandy J McGeachy, Joanne E Konkel, Haydeé L Ramos, Lai Wei, Todd S Davidson, Nicolas Bouladoux, John R Grainger, Qian Chen, Yuka Kanno, Wendy T Watford, Hong-Wei Sun, Gérard Eberl, Ethan M Shevach, Yasmine Belkaid, Daniel J Cua, Wanjun Chen, John J O'Shea.
Abstract
CD4(+) T-helper cells that selectively produce interleukin (IL)-17 (T(H)17), are critical for host defence and autoimmunity. Although crucial for T(H)17 cells in vivo, IL-23 has been thought to be incapable of driving initial differentiation. Rather, IL-6 and transforming growth factor (TGF)-β1 have been proposed to be the factors responsible for initiating specification. Here we show that T(H)17 differentiation can occur in the absence of TGF-β signalling. Neither IL-6 nor IL-23 alone efficiently generated T(H)17 cells; however, these cytokines in combination with IL-1β effectively induced IL-17 production in naive precursors, independently of TGF-β. Epigenetic modification of the Il17a, Il17f and Rorc promoters proceeded without TGF-β1, allowing the generation of cells that co-expressed RORγt (encoded by Rorc) and T-bet. T-bet(+)RORγt(+) T(H)17 cells are generated in vivo during experimental allergic encephalomyelitis, and adoptively transferred T(H)17 cells generated with IL-23 without TGF-β1 were pathogenic in this disease model. These data indicate an alternative mode for T(H)17 differentiation. Consistent with genetic data linking IL23R with autoimmunity, our findings re-emphasize the importance of IL-23 and therefore may have therapeutic implications.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20962846 PMCID: PMC3108066 DOI: 10.1038/nature09447
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962